Worldwide Clinical Trials
Worldwide Clinical Trials is a global CRO providing full-service drug development services to the pharmaceutical and biotechnology industries from Early Phase and Bioanalytical Sciences through Phase II and III trials to peri-approval studies.
|Worldwide Clinical Trials|
|Headquarters|| 3800 Paramount Parkway
Suite 400, Morrisville, NC 27560, USA
|Key people|| Neal R. Cutler, M.D.
Chief Executive Officer
|Number of employees||1,001-5,000 employees|
Founded in 1986 by Dr. Neal R. Cutler and his team, Worldwide Clinical Trials Incorporated began as an investigational site before expanding to become a global Contract Research Organization (CRO) in 1995. The business philosophy places an emphasis on site and patient focused clinical trials and research.
Known for developing revolutionary and innovative techniques in interventional clinical research, the investigative site and later the CRO both became advocates for the need of methodological rigor in the design and execution of clinical trials across therapeutic areas.
The unfaltering emphasis on follow-through and senior management oversight for all projects increased the quality, safety and the speed of the drug development and has become a hallmark of the company.
Through consistent growth and a series of strategic mergers and acquisitions, Worldwide Clinical Trials has grown to become synonymous with innovation. The personalized and committed involvement at all levels of clinical development from single-site investigators to large Phase III studies is a unique offering of the organization. In an industry characterized by explosive growth and global capability, Worldwide Clinical Trials distinctly stands out as a differentiated and scientifically driven CRO in the world today.
- AME Services
- Assay Method Research
- Bioanalytical Laboratory in Texas
- LC - MS/MS
- Protein Binding
Phase I (I-IIA) Clinical Trials
- Clinical Research Unit in San Antonio Tx
- Pharmacokinetics/ Pharmacodynamics
Phase 2-3 (II-IIIB) Clinical Trials
- The Worldwide Way
- Clinical Monitoring & Site Management
- Data Management
- Drug & Supply Depots
- Drug Safety & Pharmacovigilance
- Feasibility & Protocol Development
- Medical Monitoring
- Medical Writing
- Patient Recruitment & Retention
- Project Management
- Quality Assurance
> Rater Services
- Regulatory Affairs
Phase 4 (IV) Clinical Trials
- Drug Safety & Pharmacovigilance
- Outcomes, Epidemiology & Risk Management
- Registries & Observational Studies
> Interactive Web/ Voice Response System
- Trial Management Technologies
Top 5 Recent Tweets
|November 18, 2020||ForeignPolicy||Worldwide, there are 53 vaccine candidates in human clinical trials right now, with another 155 further back in the… https://t.co/N43uNKFXf2|
|November 19, 2020||JeaneF1MSP||That’s kind of you Andrew but congratulations really belong to researchers & scientists worldwide and especially to… https://t.co/eJtMZdbv7R|
|November 25, 2020||Medidata||Congratulations to @worldwidetrials for their 2020 Rave RTSM accreditation! Together with Worldwide Clinical Trials… https://t.co/Bozop5WhnX|
|November 25, 2020||Pavol90656430||Worldwide Clinical Trials is #hiring. Join the #UncommonCRO! @worldwidetrials https://t.co/2NUpsfahYz https://t.co/P7JNZokyFh|
Top 5 Recent News Headlines
Worldwide Clinical Trials Expert to Present On Patient Engagement at DIA 2017 June 1, 2017 Barbara Zupancic, MBA, MSc, Director, Global Patient Recruitment and Retention at Worldwide Clinical Trials (www.worldwide.com), will present at one of the life sciences industry’s key events – the annual meeting of the DIA (Drug Information Association), being held June 18-21, 2017 in Chicago, Illinois. https://www.worldwide.com/about-us/in-the-news/worldwide-clinical-trials-expert-present-patient-engagement-dia-2017/